Investigating the combined use of cannabis and prescription opioids in young adults
Co-use of cannabis and prescription opioids in emerging adults in medical settings
This study is looking at how using cannabis might change the way young adults, ages 18-25, use prescription opioids for pain after visiting a doctor, and it aims to find out what factors might lead to using both substances together so we can create better support for those who need it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11193297 on NIH RePORTER |
What this research studies
This research focuses on understanding how cannabis use affects the prescription opioid use among emerging adults aged 18-25, particularly in medical settings where opioids are prescribed for acute pain management. The study aims to identify individual risk factors that contribute to the co-use of these substances and the potential problems that may arise from it. By enrolling participants during medical encounters when opioids are prescribed, the research seeks to gather insights into their substance use patterns and psychosocial experiences. The findings could help develop targeted interventions to reduce the risks associated with opioid and cannabis co-use.
Who could benefit from this research
Good fit: Ideal candidates for this research are emerging adults aged 18-25 who are prescribed opioids for acute pain management.
Not a fit: Patients outside the age range of 18-25 or those not prescribed opioids for pain management may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies for substance use disorders among young adults.
How similar studies have performed: While there is ongoing research into substance use patterns, this specific focus on the co-use of cannabis and opioids in emerging adults is relatively novel.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Wilson, Anna Camille — Oregon Health & Science University
- Study coordinator: Wilson, Anna Camille
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.